Financials
- Market Capitalization 375.39 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2
市销率
11.96
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3122 | IPSC Century Therapeutics, Inc. - Common Stock | 2.11 USD | -0.94% | -11.72% | -8.66% | +263.79% | 380.55 M USD | ||
| 3133 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 12.91 USD | -1.53% | -10.41% | +12.85% | +95.90% | 375.40 M USD | ||
| 3142 | AVIR Atea Pharmaceuticals, Inc. - common stock | 4.70 USD | 0.00% | -4.08% | +6.82% | +46.42% | 376.13 M USD | ||
| 3174 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.62 USD | 0.00% | -6.67% | -2.12% | +11.06% | 362.77 M USD |